Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Simon Property Group Q1 FFO Rises; Revises FY 2012 Guidance - Quick Facts

RELATED NEWS
Trade SPG now with 

Simon Property Group Inc. (SPG: Quote) Friday released the results for the first quarter ended 31 March 2012, reporting rise in funds from operations, or FFO, for the first quarter at $648.7 million, or $1.82 per diluted share, compared to $570.6 million, or $1.61 per diluted share reported for the same quarter last year.

Twenty analysts polled by Thomson Reuters estimated FFO of $1.68 per share for the quarter. Analysts' estimates usually exclude special items.

Net income attributable to common stockholders for the first quarter of 2012 increased to $645.4 million, or $2.18 per diluted share, from $179.4 million, or $0.61 per diluted share, reported for the same quarter last year.

Total revenues for the first quarter improved to $1.12 billion from $1.02 billion reported in the year-ago quarter, with minimum rent revenues rising to $702.02 million from $644.33 million in the previous year. Seven analysts polled by Thomson Reuters estimated revenues of $1.05 billion for the quarter.

Looking ahead, the company revised its FFO guidance for the full year 2012, and now projects 2012 FFO in the range of $7.50 to $7.60 per share. Consensus of analysts' estimates currently sees FFO of $7.48 per share.

Click here to receive FREE breaking news email alerts for Simon Property Group Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.